{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:14:59Z","timestamp":1788552899456,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270774"],"award-info":[{"award-number":["82270774"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017127","name":"Shenzhen Government","doi-asserted-by":"publisher","award":["KCXFZ20201221173612034"],"award-info":[{"award-number":["KCXFZ20201221173612034"]}],"id":[{"id":"10.13039\/100017127","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.colsurfb.2026.116069","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:45:55Z","timestamp":1786491955000},"page":"116069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Kidney-targeted delivery of rapamycin via folic acid\u2013Mn3O4 nanoparticles for acute kidney injury therapy"],"prefix":"10.1016","volume":"268","author":[{"given":"Weinan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1222-2298","authenticated-orcid":false,"given":"Liping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2026.116069_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(24)02385-7","article-title":"Acute kidney injury","volume":"405","author":"Ostermann","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.colsurfb.2026.116069_bib2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/aas.14100","article-title":"Acute kidney injury in intensive care patients: incidence, time course, and risk factors","volume":"66","author":"Mo","year":"2022","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.colsurfb.2026.116069_bib3","article-title":"Epidemiology of acute kidney injury in the intensive care unit","volume":"2013","author":"Case","year":"2013","journal-title":"Crit. Care Res. Pract."},{"key":"10.1016\/j.colsurfb.2026.116069_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116069_bib5","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1038\/s41401-021-00620-9","article-title":"Natural products: potential treatments for cisplatin-induced nephrotoxicity","volume":"42","author":"Fang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.colsurfb.2026.116069_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41374-018-0063-2","article-title":"Cisplatin nephrotoxicity as a model of chronic kidney disease","volume":"98","author":"Shi","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.colsurfb.2026.116069_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/phar.2500","article-title":"Cisplatin-induced nephrotoxicity in an outpatient setting","volume":"41","author":"Burns","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.colsurfb.2026.116069_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.colsurfb.2026.116069_bib9","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.colsurfb.2026.116069_bib10","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.colsurfb.2026.116069_bib11","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00204-015-1633-3","article-title":"DNA damage response in cisplatin-induced nephrotoxicity","volume":"89","author":"Zhu","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.colsurfb.2026.116069_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/antiox14070775","article-title":"Mechanisms of cisplatin-induced acute kidney injury: the role of NRF2 in mitochondrial dysfunction and metabolic reprogramming","volume":"14","author":"Liu","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.colsurfb.2026.116069_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142225","article-title":"Understanding the risk factors and long-term consequences of cisplatin-associated acute kidney injury: an observational cohort study","volume":"10","author":"Bhat","year":"2015","journal-title":"PLoS. One"},{"key":"10.1016\/j.colsurfb.2026.116069_bib14","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/cancers13071572","article-title":"Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations","volume":"13","author":"McSweeney","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.116069_bib15","doi-asserted-by":"crossref","first-page":"F560","DOI":"10.1152\/ajprenal.00512.2015","article-title":"Repeated administration of low-dose cisplatin in mice induces fibrosis","volume":"310","author":"Sharp","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.colsurfb.2026.116069_bib16","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.colsurfb.2026.116069_bib17","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.3390\/ijms24076086","article-title":"Rapamycin perfluorocarbon nanoparticle mitigates cisplatin-induced acute kidney injury","volume":"24","author":"Zhou","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.116069_bib18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/ki.2012.261","article-title":"Autophagy in proximal tubules protects against acute kidney injury","volume":"82","author":"Jiang","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.colsurfb.2026.116069_bib19","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.7150\/thno.84655","article-title":"TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy","volume":"13","author":"Yu","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2026.116069_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","article-title":"Autophagy in kidney homeostasis and disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.colsurfb.2026.116069_bib21","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.34067\/KID.0003782020","article-title":"mTOR signaling in kidney diseases","volume":"1","author":"Gui","year":"2020","journal-title":"Kidney360"},{"key":"10.1016\/j.colsurfb.2026.116069_bib22","doi-asserted-by":"crossref","first-page":"F180","DOI":"10.1152\/ajprenal.00015.2012","article-title":"Mammalian target of rapamycin and the kidney. II. Pathophysiology and therapeutic implications","volume":"303","author":"Lieberthal","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.colsurfb.2026.116069_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.619730","article-title":"AMPK\/mTOR signaling in autophagy regulation during cisplatin-induced acute kidney injury","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.colsurfb.2026.116069_bib24","doi-asserted-by":"crossref","first-page":"9635","DOI":"10.1038\/s41598-025-93815-7","article-title":"mTOR inhibition limits LPS induced acute kidney injury and ameliorates hallmarks of cellular senescence","volume":"15","author":"Stasi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2026.116069_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2393262","article-title":"Mitochondrial dysfunction in acute kidney injury","volume":"46","author":"Yao","year":"2024","journal-title":"Ren. Fail."},{"key":"10.1016\/j.colsurfb.2026.116069_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/15548627.2019.1635382","article-title":"Deregulated MTOR (mechanistic target of rapamycin kinase) is responsible for autophagy defects exacerbating kidney stone development","volume":"16","author":"Unno","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.colsurfb.2026.116069_bib27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jconrel.2020.02.027","article-title":"Recent advances in nanotechnology-based drug delivery systems for the kidney","volume":"321","author":"Oroojalian","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.116069_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3892\/mmr.2021.12134","article-title":"Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy","volume":"24","author":"Lin","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.colsurfb.2026.116069_bib29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12967-014-0224-z","article-title":"Rapamycin protects kidney against ischemia reperfusion injury through recruitment of NKT cells","volume":"12","author":"Zhang","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.colsurfb.2026.116069_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41565-021-01048-2","article-title":"Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability","volume":"17","author":"Burke","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2026.116069_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204083119","article-title":"Tissue-restricted inhibition of mTOR using chemical genetics","volume":"119","author":"Wassarman","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.colsurfb.2026.116069_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ndt\/gfh639","article-title":"Nephrotoxicity of rapamycin: an emerging problem in clinical medicine","volume":"20","author":"Marti","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.colsurfb.2026.116069_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00007691-199212000-00007","article-title":"Pharmacokinetics of rapamycin: single-dose studies in the rabbit","volume":"14","author":"Honcharik","year":"1992","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.colsurfb.2026.116069_bib34","first-page":"377","article-title":"Mammalian target of rapamycin inhibitors and nephrotoxicity: fact or fiction","volume":"13","author":"Barbari","year":"2015","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.colsurfb.2026.116069_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.trim.2014.05.002","article-title":"Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes","volume":"31","author":"Shihab","year":"2014","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.colsurfb.2026.116069_bib36","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4161\/cc.8.7.8044","article-title":"Targeting mTOR with rapamycin: one dose does not fit all","volume":"8","author":"Foster","year":"2009","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.colsurfb.2026.116069_bib37","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4161\/cc.8.23.10070","article-title":"Targeting mTOR globally in cancer: thinking beyond rapamycin","volume":"8","author":"Shor","year":"2009","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.colsurfb.2026.116069_bib38","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/acs.molpharmaceut.1c00511","article-title":"Renal cell-targeted drug delivery strategy for acute kidney injury and chronic kidney disease: a mini-review","volume":"18","author":"Liu","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2026.116069_bib39","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2026.116069_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116069_bib41","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.31635\/ccschem.025.202505838","article-title":"Self-reinforced polyphenolic nanoantioxidants","volume":"7","author":"Liu","year":"2025","journal-title":"CCS Chem."},{"key":"10.1016\/j.colsurfb.2026.116069_bib42","doi-asserted-by":"crossref","first-page":"18562","DOI":"10.1021\/acsnano.3c06991","article-title":"Robust and multifunctional nanoparticles assembled from natural polyphenols and metformin for efficient spinal cord regeneration","volume":"17","author":"Yuan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.116069_bib43","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1039\/D1CS01165K","article-title":"Versatile polyphenolic platforms in regulating cell biology","volume":"51","author":"Cao","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.colsurfb.2026.116069_bib44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/nano11051084","article-title":"Applications and biological activity of nanoparticles of manganese and manganese oxides in in vitro and in vivo models","volume":"11","author":"Soba\u0144ska","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.colsurfb.2026.116069_bib45","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1039\/C7SC05476A","article-title":"ROS scavenging Mn3O4 nanozymes for in vivo anti-inflammation","volume":"9","author":"Yao","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.colsurfb.2026.116069_bib46","doi-asserted-by":"crossref","first-page":"33273","DOI":"10.1021\/acsami.3c03332","article-title":"Mn3O4 nanozyme loaded thermosensitive PDLLA-PEG-PDLLA hydrogels for the treatment of inflammatory bowel disease","volume":"15","author":"Yang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2026.116069_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12951-022-01410-z","article-title":"Inflammation-sensing catalase-mimicking nanozymes alleviate acute kidney injury via reversing local oxidative stress","volume":"20","author":"Choi","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2026.116069_bib48","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.7150\/thno.39560","article-title":"Probing and enhancing ligand-mediated active targeting of tumors using sub-5 nm ultrafine iron oxide nanoparticles","volume":"10","author":"Xu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2026.116069_bib49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1517\/17425247.5.3.309","article-title":"Targeted drug delivery via folate receptors","volume":"5","author":"Zhao","year":"2008","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/j.colsurfb.2026.116069_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122329","article-title":"Folate-conjugated nanomedicines for selective inhibition of mTOR signaling in polycystic kidneys at clinically relevant doses","volume":"302","author":"Pala","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2026.116069_bib51","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s42003-021-02546-8","article-title":"Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice","volume":"4","author":"Adhikari","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.colsurfb.2026.116069_bib52","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.2147\/IJN.S215142","article-title":"Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer","volume":"14","author":"Mahalunkar","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2026.116069_bib53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1634\/theoncologist.2016-0319","article-title":"A systematic review of strategies to prevent cisplatin-induced nephrotoxicity","volume":"22","author":"Crona","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.colsurfb.2026.116069_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2022.100917","article-title":"Folate receptor as a biomarker and therapeutic target in solid tumors","volume":"47","author":"Young","year":"2023","journal-title":"Curr. Probl. Cancer"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526006570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526006570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:45:28Z","timestamp":1788551128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526006570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":54,"alternative-id":["S0927776526006570"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116069","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney-targeted delivery of rapamycin via folic acid\u2013Mn3O4 nanoparticles for acute kidney injury therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116069"}}